Teva Pharmaceutical Industries Limited
Organization details
- Legal name
- Teva Pharmaceutical Industries Limited
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Israel
- Headquarters city
- TEL Aviv
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- TEVA
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000818686
- Wikidata ID
- Q898750
Board of directors
-
Amir Elstein · DirectorSince 2023
-
Chen Lichtenstein · DirectorSince 2024
-
David J. Brailer · DirectorSince 2026
-
Gerald M. Lieberman · DirectorSince 2023
-
Janet S. Vergis · DirectorSince 2023
-
Perry Nisen · DirectorSince 2023
-
Roberto Mignone · DirectorSince 2023
-
Ronit Satchi-Fainaro · DirectorSince 2023
-
Rosemary A. Crane · DirectorSince 2023
-
Sol J. Barer · DirectorSince 2023
-
Tal Zvi Zaks · DirectorSince 2023
-
Varda Shalev · DirectorSince 2023
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
71.9%
Board connections
5 of this board's directors also sit on 7 other boards. 4 are in the same sector.
- via Rosemary A. Crane
- via Janet S. Vergis
-
DENTSPLY SIRONA Inc. Same sectorvia Janet S. Vergis
-
Entera Bio Ltd. Same sectorvia Gerald M. Lieberman
-
Guardant Health Inc. Same sectorvia Roberto Mignone
-
Tarsus Pharmaceuticals Inc. Same sectorvia Rosemary A. Crane
- via Amir Elstein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $126,400,945
- 66 sales by 15 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 12, 2026 | Sabag Mark Officer (See "Remarks") | Option exercise | +44,710 | $34.90 | $1,560,379 |
| Nov 12, 2026 | Sabag Mark Officer (See "Remarks") | Open-market sale | −44,710 | $44.14 | $1,973,544 |
| Nov 11, 2026 | Daniell Richard Officer (EVP, Europe Commercial) | Option exercise | +20,003 | $34.70 | $694,104 |
| Nov 11, 2026 | Daniell Richard Officer (EVP, Europe Commercial) | Open-market sale | −20,003 | $42.80 | $856,154 |
| Nov 10, 2026 | Richard D. Francis Officer (President and CEO) | Open-market sale | −250,000 | $42.24 | $10,559,175 |
| Nov 9, 2026 | Daniell Richard Officer (EVP, Europe Commercial) | Option exercise | +25,000 | $34.70 | $867,500 |
| Nov 9, 2026 | Weiss Amir Officer (Chief Accounting Officer) | Option exercise | +7,755 | $34.70 | $269,099 |
| Nov 9, 2026 | Daniell Richard Officer (EVP, Europe Commercial) | Open-market sale | −25,000 | $42.91 | $1,072,790 |
| Nov 9, 2026 | Weiss Amir Officer (Chief Accounting Officer) | Open-market sale | −662 | $43.15 | $28,565 |
| Nov 9, 2026 | Weiss Amir Officer (Chief Accounting Officer) | Open-market sale | −7,093 | $43.03 | $305,247 |
| Nov 9, 2026 | Weiss Amir Officer (Chief Accounting Officer) | Open-market sale | −9,534 | $43.03 | $410,238 |
| Nov 5, 2026 | Sabag Mark Officer (See "Remarks") | Option exercise | +46,000 | $34.90 | $1,605,400 |
| Nov 5, 2026 | Sabag Mark Officer (See "Remarks") | Open-market sale | −46,000 | $41.93 | $1,928,729 |
| Nov 4, 2026 | Bergwerk Dov Officer (Interim Cheif Legal Officer) | Option exercise | +17,505 | $34.70 | $607,424 |
| Nov 4, 2026 | Bergwerk Dov Officer (Interim Cheif Legal Officer) | Open-market sale | −17,505 | $41.72 | $730,309 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Teva Pharmaceutical Industries Limited
How many directors are on Teva Pharmaceutical Industries Limited's board?
Teva Pharmaceutical Industries Limited's board has 12 directors: Amir Elstein, Chen Lichtenstein, David J. Brailer, Gerald M. Lieberman, Janet S. Vergis, Perry Nisen, Roberto Mignone, Ronit Satchi-Fainaro, Rosemary A. Crane, Sol J. Barer and 2 others.
Are Teva Pharmaceutical Industries Limited insiders buying or selling shares?
Over the last 12 months, Teva Pharmaceutical Industries Limited insiders made no open-market purchases and sold $126.4 million of shares in 66 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="teva-pharmaceutical-industries-limited"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.